Valuation: Viyash Scientific Limited

Market Cap 8.88TCr 94Cr 84Cr 77Cr 70Cr 130.83Cr 133Cr 928.62Cr 367.65Cr 4.65TCr 351.05Cr 343.59Cr 15TCr P/E 2027 *
29.1x
P/E 2028 * 16.6x
Enterprise Value 8.88TCr 94Cr 84Cr 77Cr 70Cr 130.83Cr 133Cr 928.62Cr 367.65Cr 4.65TCr 351.05Cr 343.59Cr 15TCr EV / Sales 2027 *
2.28x
EV / Sales 2028 * 2.01x
Free-Float
44.4%
Yield 2027 *
-
Yield 2028 * -
1 day-2.07%
1 week-9.90%
Current month-13.74%
1 month-19.12%
3 months-20.81%
6 months-2.93%
Current year-2.26%
1 week 197
Extreme 197
229.85
1 month 197
Extreme 197
253.35
Current year 178.4
Extreme 178.4
297.9
1 year 178.4
Extreme 178.4
297.9
3 years 91.85
Extreme 91.85
297.9
5 years 61.8
Extreme 61.8
297.9
10 years 42.45
Extreme 42.45
336.4
Manager TitleAgeSince
Chief Executive Officer 62 16/12/2025
Director of Finance/CFO - 01/01/2026
Chief Tech/Sci/R&D Officer - 05/02/2026
Director TitleAgeSince
Chairman 78 25/08/2025
Director/Board Member 67 25/08/2020
Director/Board Member 57 11/04/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.07%-9.90%-1.14%+94.67% 96Cr
-1.89%+1.04%+54.69%+120.26% 1,16500Cr
-1.63%+3.28%+37.13%+74.34% 64TCr
-0.26%+0.23%+25.33%+97.66% 50TCr
-0.31%+3.09%+43.92%+64.55% 38TCr
-1.02%-0.60%+66.40%+40.37% 36TCr
-0.68%+2.65%+22.46%+51.48% 30TCr
-1.20%+3.04%+2.62%+26.97% 27TCr
-1.81%+1.86%+50.41%+61.33% 24TCr
-0.71%+0.42%+29.90%+102.22% 19TCr
Average -1.10%+1.49%+33.17%+73.38% 40.56TCr
Weighted average by Cap. -1.19%+3.17%+41.02%+82.23%

Financials

2027 *2028 *
Net sales 3.9TCr 41Cr 37Cr 34Cr 31Cr 57Cr 58Cr 407.78Cr 161.44Cr 2.04TCr 154.16Cr 150.88Cr 6.44TCr 4.43TCr 47Cr 42Cr 38Cr 35Cr 65Cr 66Cr 463.07Cr 183.33Cr 2.32TCr 175.06Cr 171.34Cr 7.31TCr
Net income 343.83Cr 3.62Cr 3.23Cr 2.99Cr 2.71Cr 5.07Cr 5.15Cr 36Cr 14Cr 180.15Cr 14Cr 13Cr 567.95Cr 564.53Cr 5.95Cr 5.31Cr 4.91Cr 4.45Cr 8.32Cr 8.46Cr 59Cr 23Cr 295.78Cr 22Cr 22Cr 932.51Cr
Net Debt - -
Projected Income Statement - Annual - Viyash Scientific Limited
Logo Viyash Scientific Limited
Viyash Scientific Limited, formerly SeQuent Scientific Limited, is an India-based integrated pharmaceutical company with a global footprint, operating in the domains of animal health (active pharmaceutical ingredients (APIs), and finished dosage formulations) and analytical services. The Company has eight manufacturing facilities, based in India, Turkey, Brazil, Spain and Germany. It is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It specializes in analytical and bioanalytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It offers analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer-developed methods or in-house method development.
Employees
2,900
Date Price Change Volume
23/26/23 ₹203.45 -2.07% 5,02,871
22/26/22 ₹207.75 -3.03% 1,62,356
21/26/21 ₹214.25 -3.08% 2,22,677
19/26/19 ₹221.05 -2.21% 1,77,242
16/26/16 ₹226.05 +0.11% 1,02,560
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Viyash Scientific Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
203.45INR
Average target price
326.00INR
Spread / Average Target
+60.24%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Viyash Scientific Limited
  1. Stock Market
  2. Stocks
  3. VIYASH Stock